SensÈn Revenue
Nanotechnology Research • • 1-10 Employees
$
SensÈn revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Nanotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Key Contact at SensÈn
Madline Sauvage
CEO & Co-Founder
Company overview
| Headquarters | XX |
| NAICS | 541713 |
| Employees | 1-10 |
About SensÈn
At SensÈn, we’re advancing precision oncology by developing cutting-edge biomarker detection medical devices for breast cancer. Our mission is to help oncologists better track tumor evolution and tailor treatments to each patient’s unique biology. Built on years of academic research, SensÈn aims to offer a next-generation solution to meet the growing demand for reliable companion tests in personalized cancer care.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
C-Suite
Employees by Department
SensÈn has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
SensÈn has never raised funding before.
Netherlands
India
United States
United Kingdom
Frequently asked questions
SensÈn is located in XX.
SensÈn generates an estimated annual revenue of $85,555. This revenue figure reflects the company's market position and business performance in its industry.
SensÈn has an estimated valuation of $273,776. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
SensÈn has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
